Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cryo-Cell International, Inc.
Interim CEO, president named to lead strategic transformation
May 14th, 2003
Cryo-Cell International, Inc., (CCEL) announced certain management additions. The company also announced that it has requested an extension for the filing of its results for the quarter ended February 28, 2003, because it is reviewing certain revenue recognition policies. The company announced that Mercedes Walton, chairman of the board of directors, will assume additional responsibilities on an interim basis as chairman and CEO. This appointment will provide sufficient time for the board's search committee to identify a replacement for John Hargiss, former president and CEO, who resigned on April 8, 2003. Walton has served as...
Source: Biotech Week (2003-05-14)
|
